Lilly Continues Positive Outlook For Migraine Treatment

Posted: Updated:
INDIANAPOLIS -

Indianapolis-based Eli Lilly and Co. (NYSE: LLY) says a 12-month Phase 3 study of a migraine treatment has shown continued positive results. The pharmaceutical giant says the study for galcanezumab showed a "statistically significant reduction in the number of monthly migraine headache days" among patients.

Lilly says the treatment "demonstrated a positive safety and tolerability profile in patients with migraine, consistent with previous studies." Patients received two different doses and the company says there was "no clinically meaningful difference" in the rate of adverse effects between the dosages. 

Lilly's previously-announced plans to submit a Biologics License Application to the U.S. Food and Drug Administration remain set for the second half of 2017. The company also plans to submit to other regulatory agencies throughout the world.

"These long-term results are significant for the millions of Americans with migraine. They reinforce the efficacy and safety profile of galcanezumab while supporting its potential use as a self-administered, monthly injection," said Christi Shaw, president of Lilly Bio-Medicines. "After more than two decades of research, Lilly is excited to submit galcanezumab to the FDA as a new potential treatment option that can provide more migraine-free days for people suffering with migraine."

Lilly is presenting the results of the study at the 18th Congress of the International Headache Society in Vancouver. The company also plans to submit the findings for publication in a peer-reviewed journal "in the coming year."

The announcement comes just one day after Lilly detailed plans for a global restructuring, affecting about 3,500 employees. The company said the move will allow it to invest in the next generation of new medicines.

  • Perspectives

    • Increasing Women Leaders in Companies and Associations

      As members of an industry largely populated by male professionals, we see firsthand the need for more diversity. As Katie Culp, president of KSM Location Advisors, noted in a recent blog, diversity leads to better business decisions.

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • Valpo Taking 'Difficult' Actions Involving Law School

      Valparaiso University says its law school is facing "severe financial challenges," deeming the 130-year-old program "financially unsustainable for the foreseeable future." The administration has decided to suspend first-year law school class admissions next fall and the university is exploring alternatives for the future, including affiliating the law school with another institution or relocating it to a market with "perceived greater demand."

    • Construction Begins on $25M Assisted Living Facility

      Officials in Noblesville have broken ground on a $25 million assisted living and memory care facility. The four-story, 105,000-square-foot Heritage Woods of Noblesville will include 124 studio and one-bedroom apartments and create nearly 80 full-time and part-time jobs.

    • Opioid Withdrawal Treatment Lands FDA Clearance

      The U.S. Food and Drug Administration has given clearance for a medical device developed in Indiana to help treat symptoms of opioid withdrawal. The device, known as the NSS-2 BRIDGE, was created by Innovative Health Solutions Inc. in Versailles.

    • New COO at Elevate Ventures

      Indianapolis-based Elevate Ventures has named Ken Miller chief operating officer. The technology industry veteran most recently served as partner at Indianapolis-based DeveloperTown. Chief Executive Officer Chris LaMothe says "with Ken on board, our statewide team is growing exponentially in terms of experience and passion for entrepreneurship in Indiana."

    • Salesforce Unveils Indy Training Program

      Salesforce (NYSE: CRM), which in May said it would add 500 new local apprentices by 2020 in Indianapolis, is launching Salesforce Pathfinder Training in the city. The company says the program will give participants skills and business training they need to become administrators or developers in the Salesforce ecosystem, which it calls two of the hottest jobs in tech. Veterans, professionals looking to re-enter the work force and youth who are not working or in school will...